Pregabalin · Geriatric safety

Explore medicine guides

Pregabalin in Older Adults: Falls, Dosage & Safety Guide

Understand the unique risks for adults aged 65 and older taking Pregabalin: fall prevention, renal dosing, cognitive side effects, and safe management.

✓ UK prescribing context✓ Plain-language answers✓ Linked medical sources
Medical information: This page provides general educational information for people in the UK. It is not a substitute for advice from a qualified healthcare professional.

Use this guide to

01UnderstandWhat Pregabalin is used for and how it works.
02CheckDosage, interactions, side effects and warnings.
03PrepareBetter questions for your GP, pharmacist or prescriber.
Pregabalin at a glanceStart with the points most relevant to you
Original productGenuine UK-licensed medicine, supplied through the authorised pharmacy process.
Common usesNerve pain, some seizures and generalised anxiety disorder.
Key cautionDrowsiness and dizziness can affect driving and balance.
Before changing treatmentSpeak with a prescriber before reducing or stopping it.
1
Quick answer: Adults aged 65 and older require extra care with Pregabalin. Due to natural age-related declines in kidney function and increased sensitivity of the central nervous system, older people are at significantly higher risk of dizziness, unsteadiness, confusion, and serious falls (including hip fractures). Prescribers in the UK start older adults at very low doses (such as 25mg daily) and titrate slowly with close monitoring.

Why older adults are more vulnerable to Pregabalin

Pharmacological changes that occur naturally as the body ages alter both the pharmacokinetics (how the body handles the drug) and pharmacodynamics (how the drug affects the brain):

  • Reduced renal clearance: Glomerular filtration in the kidneys declines by roughly 1% per year after age 40. Even in an older person with no known kidney disease, clearance of Pregabalin is often 30% to 50% lower than in a younger adult.
  • Enhanced blood-brain barrier permeability: More medication penetrates the central nervous system, producing deeper sedation and dizziness at lower blood levels.
  • Reduced physiological reserve: Blunted balance reflexes and reduced muscle strength mean that mild lightheadedness can easily result in a catastrophic fall.

Fall risk and mobility complications

According to the British Geriatrics Society (BGS), psychotropic and sedative medications (including gabapentinoids) are among the leading modifiable risk factors for falls in older people.

Pregabalin impairs motor coordination and balance through its dampening effect on cerebellar circuits:

  • Postural instability: Stumbling, unsteady gait, and slow recovery if foot placement is misplaced.
  • Postural hypotension: Dizziness or fainting upon standing up from a bed or chair.
  • Serious clinical consequences: Fractured neck of femur (broken hip), wrist fractures, subdural haematomas (bleeding on the brain after minor head knocks), and long hospital stays leading to loss of independence.
Home Safety Checklist for Carers and Families:
  • Remove loose rugs, floor mats, and clutter from hallways and stairs.
  • Install bright night lights in bedrooms and bathrooms to assist nighttime visits to the toilet.
  • Advise the person to sit on the edge of the bed for 30 seconds before standing up.
  • Ensure walking sticks or frames are within arm’s reach at all times.

Cognitive side effects, confusion and delirium

In older adults, particularly those with pre-existing mild cognitive impairment (MCI) or dementia, Pregabalin can cause marked neurocognitive side effects:

  • Brain fog and memory lapses: Forgetting recent conversations, repeating questions, or misplacing essential items.
  • Drug-induced delirium: Acute confusion, disorientation to time and place, hallucinations, or sudden changes in sleep-wake cycles.

If an older relative becomes acutely confused within days or weeks of starting Pregabalin or changing dose, contact their GP or NHS 111 immediately. In many cases, stepping the dose down resolves the confusion without permanent harm.

Polypharmacy and drug burden in the elderly

Many older people take multiple long-term prescription medicines for cardiovascular disease, arthritis, and diabetes. Combining Pregabalin with other medications can amplify risks:

Co-Prescribed MedicineCommon ExamplesSpecific Risk in Older Adults
Opioid AnalgesicsCodeine, co-codamol, morphineExtreme sedation, severe constipation, acute respiratory depression.
Sedatives / Z-DrugsZopiclone, diazepam, temazepamProfound nighttime unsteadiness, nocturnal falls, morning hangover confusion.
Blood Pressure MedicinesAmlodipine, ramipril, bendroflumethiazideAdditive low blood pressure (orthostatic hypotension) upon standing.
Sedating AntihistaminesPromethazine, chlorphenamineUrinary retention, acute worsening of glaucoma, and dry mouth.

Starting low and going slow: Geriatric prescribing

NHS clinical guidelines recommend a conservative approach when initiating Pregabalin in older adults:

  • Starting dose: Often 25mg once daily at bedtime (which takes advantage of the sedative effect to assist sleep while minimizing daytime dizziness).
  • Dose escalation: Increasing by only 25mg or 50mg every 1 to 2 weeks, only if the medicine is well tolerated and pain or anxiety remains uncontrolled.
  • Kidney testing: Routine blood tests (eGFR / creatinine clearance) before starting and at least annually thereafter. Read our kidney disease guide.

Questions for patients and family carers to ask the GP

  • Has my kidney function (eGFR) been checked in the last 6 months to ensure this dose is safe?
  • Could any of my daytime sleepiness or unsteady walking be caused by my Pregabalin dose?
  • Are there non-drug treatments (such as physiotherapy or gentle pacing) that could allow us to lower my medication dose?
  • If I experience a fall, what is our action plan for reviewing my prescriptions?

Clinical sources and references

Draft publication status: This page is prepared for a UK audience but has not yet received qualified clinical review.
Author: MediHarbour Editorial Team · Medical reviewer: To be assigned · Review date: Pending · Draft updated: 1 October 2026.
Sources should be checked against current NHS, MHRA, NICE, UK product information and peer-reviewed evidence before publication. Read our editorial policy.